Recovery of Tenofovir-induced Nephrotoxicity following Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Human Immunodeficiency Virus-Positive Patients.

Jun Won Seo Kichun Kim Kang Il Jun Chang Kyung Kang Song Mi Moon Kyoung-Ho Song Ji Hwan Bang Eu-Suk Kim Hong Bin Kim Wan Beom Park Nam Joong Kim Pyeong Gyun Choe Pyoeng Gyun Choe Myoung-don Oh

Published in: Infection & chemotherapy (2020)

Tenofovir-induced nephrotoxicity in HIV-positive patients receiving TDF was mostly reversible after changing to TAF. Thus, TAF-containing regimens can be administered safely to HIV-positive patients with tenofovir-induced nephrotoxicity.

Keyphrases

antiretroviral therapy
hiv positive
human immunodeficiency virus
hiv infected
hiv aids
men who have sex with men
drug induced
diabetic rats
high glucose
south africa
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis